Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies (Tables)

v3.25.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Diluted Net Loss Per Share

For the years ended December 31, 2024 and 2023, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

 

    December 31,     December 31,  
    2024     2023  
    (Shares)     (Shares)  
Warrants excluding pre-funded warrant     5,402,306       233,818  
Series A convertible preferred stock     -       283,512  
Total common stock equivalents     5,402,306       517,330